Australasian Professional Society on Alcohol and other Drugs (APSAD)

Australasian Professional Society on Alcohol and other Drugs (APSAD) APSAD is Australia's leading multidisciplinary organisation for professionals involved in AOD Online access to all back issues of the Review.

The Australasian Professional Society on Alcohol & other Drugs (APSAD) is the Asia Pacific's leading multidisciplinary organisation for professionals involved in the alcohol and other drug field. APSAD is dedicated to increasing the profile of the issues related to the use of alcohol and other drugs, through the dissemination of information from the wide range of professions involved in this field

. In addition, we strive to promote improved standards in clinical practice and in research into this and allied subjects. It also provides a network of drug and alcohol professionals in Australia, New Zealand and the Asia Pacific. Through its internationally recognised scientific journal, the Drug and Alcohol Review, and its annual Scientific Conference, APSAD provides a forum for the latest research on the nature, prevention and treatment of physical, psychological and social problems related to the use of psychoactive substances. APSAD is dedicated to:

promoting evidence-based improvements in the treatment and prevention of drug and alcohol-related problems
raising awareness about the problems related to the use of alcohol and other drugs
promoting best standards in research in the drug and alcohol field
providing development and support to professionals working in the drug and alcohol field. ACTIVITIES

APSAD offers various forms of professional development for health professionals. Subscription to the Society's scientific journal, the Drug and Alcohol Review. Discounted registration to the Annual APSAD Scientific Conference. Discounted registration at selected AOD conferences including the DANA conference
Subscription to the APSAD e-newsletter
APSAD offers a range of other activities for members. A conference is held annually, with this year's conference scheduled to take place in Sydney 30 October - 2 November. Regional conferences and workshops are also supported, often jointly with other professional organisations. APSAD also produces a bi-monthly newsletter, to keep members up-to- date and provide a forum for discussion. The Drug and Alcohol Review is the Society's official journal. Celebrating its 34th year of publication, the journal is listed on the international database, Medline. Published bi-monthly as of 2005, the Review presents original research, policy development and information in the drug and alcohol research field.

🆕 Pricing Dynamics in European Illicit Drug Markets: Evidence From Wholesale, Retail and Margin RelationshipsEvangelos V...
25/06/2026

🆕 Pricing Dynamics in European Illicit Drug Markets: Evidence From Wholesale, Retail and Margin Relationships

Evangelos Vasileiou

https://doi.org/10.1111/dar.70187

Ελληνικό Μεσογειακό Πανεπιστήμιο - Hellenic Mediterranean University

There's still time to register for today's webinar - Strengthening Syphilis Awareness and Care in AOD Services webinar.S...
25/06/2026

There's still time to register for today's webinar - Strengthening Syphilis Awareness and Care in AOD Services webinar.

Syphilis rates have tripled in Australia over the past decade, highlighting the urgent need for greater awareness, screening and early intervention across a range of health and community settings. People accessing alcohol and other drug (AOD) services often face additional barriers to care and are at increased risk of sexually transmissible infections (STIs), including syphilis. Staff working in these settings are uniquely positioned to support timely access to testing, treatment, and care.

Presented by Australasian Professional Society on Alcohol and other Drugs (APSAD) and ASHM this free one-hour webinar is designed for both clinical and non-clinical staff working in AOD services. The session will explore the current syphilis landscape in Australia and key considerations for AOD settings, alongside practical insights, real-world examples, and peer perspectives to strengthen confidence in supporting people at higher risk to access sexual health care.

Learning outcomes:
On completion of this session, participants will be able to:
- Describe the current syphilis context, including current trends and concerns.
- Recall priority populations for syphilis and related considerations relevant to AOD settings.
- Recognise key signs and symptoms of syphilis.
- Identify testing, referral, and follow-up considerations for syphilis and congenital syphilis.
- Identify practical strategies, models of care and trauma-informed approaches to reduce barriers and support timely access to care.

Target audience: Clinical and non-clinical staff working across AOD care.

Register: https://us02web.zoom.us/webinar/register/WN_QLnIFdspSlCMb9I3daGDrQ

Australian Injecting & Illicit Drug Users League - AIVL

🆕 Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Pr...
24/06/2026

🆕 Health, Social and Recidivism Outcomes Among People Who Have Been Incarcerated in New South Wales, Australia: Study Protocol and Cohort Profile for the Prison Outcomes STudy (POST)

Louisa Degenhardt, Michael Farrell, Michael Doyle, Jack Stone, Chrianna Bharat, Matt Hickman, Marianne Martinello, Don Weatherburn, Kimberlie Dean, Joe Coyte, Christel Macdonald, Mary Ellen Harrod, Luke Grant, Gloria Larman, Peter Vickerman, Colette McGrath, Peter Thompson, Alison Churchill, Greg Dore, Thomas Santo Jr

National Drug and Alcohol Research Centre (NDARC), UNSW, University of Sydney, University of Bristol, Kirby Institute, The Glen Rehab, NUAA NSW, Corrective Services NSW, Women's Justice Network, Justice Health NSW

https://doi.org/10.1111/dar.70161

🆕 ‘We Feel Invisible a Lot of the Time’: Insights Into the Roles of Alcohol and Other Drug Lived and Living Experience W...
23/06/2026

🆕 ‘We Feel Invisible a Lot of the Time’: Insights Into the Roles of Alcohol and Other Drug Lived and Living Experience Workers

Ariel D. Roxburgh, Shalini Arunogiri, Lauren Findlay, Victoria Manning

https://doi.org/10.1111/dar.70199

Monash University, Monash Addiction Research Centre, Turning Point

🆕 Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploratio...
22/06/2026

🆕 Perceptions of Buprenorphine With Naloxone Treatment and the Fear of Precipitated Withdrawal: A Qualitative Exploration With HIV Prevention Trials Network 094 INTEGRA Participants and Staff

Rose A. Schmidt, Amaya Perez-Brumer, Peter Davidson, Steve Shoptaw, Nabila El-Bassel, Philip Andrew, Jayla Harris, Omar Nieto, Sydney Bornstein, Rashaunna Redd, Jessica Yeager, David Goodman-Meza, Albert L. Hasson, Marc Seigel, Cecile Denis, Renee El-Krab, Laramie R. Smith

https://doi.org/10.1111/dar.70198

Dalla Lana School of Public Health, University of Toronto, UC San Diego, UCLA, Columbia University, HIV Prevention Trials Network, The George Washington University, UTHealth Houston, Perelman School of Medicine at the University of Pennsylvania

🆕 On the Label: Implementation of Health Warnings on Alcohol Products in 13 European Countrieshttps://doi.org/10.1111/da...
22/06/2026

🆕 On the Label: Implementation of Health Warnings on Alcohol Products in 13 European Countries

https://doi.org/10.1111/dar.70185

WHO Regional Office for Europe, Maastricht University, CAMH, University of Toronto, Dalla Lana School of Public Health, The George Institute for Global Health

Daša Kokole, Maria Neufeld, Daniela Correia, Jürgen Rehm, Simone Pettigrew, Catherine Paradis, Carina Ferreira Borges, Almudena Núñez Fernández-Shaw, António Pedro Pinho, Claudia Pereira, Eglė Juškevičiūtė, Evangelia Savvidou, Jasmijn de Veld, Laura Plešnar, Leander Mergaert, Lucía Clemente Bermúdez, Melissa Sawaya, Mia Šelović, Miglė Kiguolytė, Mikołaj Patalong, Patrik Senica, Pau Ladero Palacio, Saloni Mitra, Sara Suarez Tostado

📢 Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain-Related Outcomes Among People With Non-Heroin Opi...
19/06/2026

📢 Differential Impacts of Methadone and Buprenorphine/Naloxone on Pain-Related Outcomes Among People With Non-Heroin Opioid Use Disorder: Secondary Analyses From a Pragmatic Canadian Multisite Trial

Katie Lyman, JinCheol Choi, Didier Jutras-Aswad, Bernard L. E. Foll, Sukhpreet Klaire, M. Eugenia Socias

https://doi.org/10.1111/dar.70190

University of British Columbia, British Columbia Centre on Substance Use, Centre de recherche du CHUM, Université de Montréal, University of Toronto, CAMH, Dalla Lana School of Public Health, Waypoint Centre For Mental Health Care, Providence Health Care

🆕 Personality Functioning and Antisociality of Youth Accessing Residential Substance Use Withdrawal in AustraliaNathan A...
18/06/2026

🆕 Personality Functioning and Antisociality of Youth Accessing Residential Substance Use Withdrawal in Australia

Nathan Akoka, Ajibola Akintola, Alexandre A. Guerin, Ashley L. Dunne, Michael Daffern, Holly Bowman, Andrew Bruun, Enrico Cementon, Andrew Chanen, David Coghill, Amelia Lopatecki, Edward Mullen, Gillinder Bedi

https://doi.org/10.1111/dar.70200

Swinburne University of Technology, Youth Support + Advocacy Service, The University of Melbourne, Orygen

🆕 Accuracy of Patient-Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency D...
17/06/2026

🆕 Accuracy of Patient-Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of Australia

Marjan J. Nijmeijer, Jennifer L. Smith, Courtney Weber, Bas W. J. Bens, Daniel M. Fatovich, Shaun L. Greene, Jennifer L. Schumann, Paul Dessauer, Rebekka Syrjanen, Katherine Z. Isoardi, Keith Harris, Sam Alfred, Viet Tran, Ewoud ter Avest

https://doi.org/10.1111/dar.70193

University of Groningen, The University of Western Australia, Harry Perkins Institute of Medical Research, East Metropolitan Health Service, Austin Health, The University of Melbourne, Monash University, Peer Based Harm Reduction WA, National Drug and Alcohol Research Centre (NDARC), The University of Queensland

🆕 Etomidate-Adulterated Va**ng: Fragmented Global Drug Control and Public Health RisksNicholas Lassi, Su Jianghttps://do...
16/06/2026

🆕 Etomidate-Adulterated Va**ng: Fragmented Global Drug Control and Public Health Risks

Nicholas Lassi, Su Jiang

https://doi.org/10.1111/dar.70188

Southwest University of Political Science and Law, Peking University

Address

L3 160 Clarence Street
Sydney, NSW
2000

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Australasian Professional Society on Alcohol and other Drugs (APSAD) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category